Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 Aug;47(8):651–656. doi: 10.1136/thx.47.8.651

The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

M Messent 1, M J Griffiths 1
PMCID: PMC463931  PMID: 1412124

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  2. Ashbaugh D. G., Bigelow D. B., Petty T. L., Levine B. E. Acute respiratory distress in adults. Lancet. 1967 Aug 12;2(7511):319–323. doi: 10.1016/s0140-6736(67)90168-7. [DOI] [PubMed] [Google Scholar]
  3. Bernard G. R., Luce J. M., Sprung C. L., Rinaldo J. E., Tate R. M., Sibbald W. J., Kariman K., Higgins S., Bradley R., Metz C. A. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 Dec 17;317(25):1565–1570. doi: 10.1056/NEJM198712173172504. [DOI] [PubMed] [Google Scholar]
  4. Bessler H., Gilgal R., Djaldetti M., Zahavi I. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol. 1986 Dec;40(6):747–754. doi: 10.1002/jlb.40.6.747. [DOI] [PubMed] [Google Scholar]
  5. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  6. Bihari D. J., Tinker J. The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis. Intensive Care Med. 1988;15(1):2–7. doi: 10.1007/BF00255627. [DOI] [PubMed] [Google Scholar]
  7. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. doi: 10.1056/NEJM198709103171101. [DOI] [PubMed] [Google Scholar]
  8. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989 May;17(5):389–393. [PubMed] [Google Scholar]
  9. Bone R. C., Slotman G., Maunder R., Silverman H., Hyers T. M., Kerstein M. D., Ursprung J. J. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest. 1989 Jul;96(1):114–119. doi: 10.1378/chest.96.1.114. [DOI] [PubMed] [Google Scholar]
  10. Brigham K. L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed] [Google Scholar]
  11. Bysani G. K., Shenep J. L., Hildner W. K., Stidham G. L., Roberson P. K. Detoxification of plasma containing lipopolysaccharide by adsorption. Crit Care Med. 1990 Jan;18(1):67–71. doi: 10.1097/00003246-199001000-00015. [DOI] [PubMed] [Google Scholar]
  12. Coccia M. T., Waxman K., Soliman M. H., Tominaga G., Pinderski L. Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med. 1989 Jan;17(1):36–38. doi: 10.1097/00003246-198901000-00009. [DOI] [PubMed] [Google Scholar]
  13. Cochrane C. G., Spragg R., Revak S. D. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest. 1983 Mar;71(3):754–761. doi: 10.1172/JCI110823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Demling R. H. Role of prostaglandins in acute pulmonary microvascular injury. Ann N Y Acad Sci. 1982;384:517–534. doi: 10.1111/j.1749-6632.1982.tb21397.x. [DOI] [PubMed] [Google Scholar]
  15. Donnelly S. C., Haslett C. Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome. Thorax. 1992 Apr;47(4):260–263. doi: 10.1136/thx.47.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Endres S., Ghorbani R., Kelley V. E., Georgilis K., Lonnemann G., van der Meer J. W., Cannon J. G., Rogers T. S., Klempner M. S., Weber P. C. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989 Feb 2;320(5):265–271. doi: 10.1056/NEJM198902023200501. [DOI] [PubMed] [Google Scholar]
  17. Exley A. R., Cohen J., Buurman W., Owen R., Hanson G., Lumley J., Aulakh J. M., Bodmer M., Riddell A., Stephens S. Monoclonal antibody to TNF in severe septic shock. Lancet. 1990 May 26;335(8700):1275–1277. doi: 10.1016/0140-6736(90)91337-a. [DOI] [PubMed] [Google Scholar]
  18. Ferrari-Baliviera E., Mealy K., Smith R. J., Wilmore D. W. Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg. 1989 Dec;124(12):1400–1405. doi: 10.1001/archsurg.1989.01410120046010. [DOI] [PubMed] [Google Scholar]
  19. Fowler A. A., Hamman R. F., Good J. T., Benson K. N., Baird M., Eberle D. J., Petty T. L., Hyers T. M. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983 May;98(5 Pt 1):593–597. doi: 10.7326/0003-4819-98-5-593. [DOI] [PubMed] [Google Scholar]
  20. Fowler A. A., Hamman R. F., Zerbe G. O., Benson K. N., Hyers T. M. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis. 1985 Sep;132(3):472–478. doi: 10.1164/arrd.1985.132.3.472. [DOI] [PubMed] [Google Scholar]
  21. Fox R. B. Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest. 1984 Oct;74(4):1456–1464. doi: 10.1172/JCI111558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Frostell C., Fratacci M. D., Wain J. C., Jones R., Zapol W. M. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991 Jun;83(6):2038–2047. doi: 10.1161/01.cir.83.6.2038. [DOI] [PubMed] [Google Scholar]
  23. Greenman R. L., Schein R. M., Martin M. A., Wenzel R. P., MacIntyre N. R., Emmanuel G., Chmel H., Kohler R. B., McCarthy M., Plouffe J. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. 1991 Aug 28;266(8):1097–1102. [PubMed] [Google Scholar]
  24. Hallman M., Spragg R., Harrell J. H., Moser K. M., Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982 Sep;70(3):673–683. doi: 10.1172/JCI110662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hamasaki Y., Mojarad M., Saga T., Tai H. H., Said S. I. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis. 1984 May;129(5):742–746. doi: 10.1164/arrd.1984.129.5.742. [DOI] [PubMed] [Google Scholar]
  26. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Craddock P. R., Jacob H. S. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet. 1980 May 3;1(8175):947–949. doi: 10.1016/s0140-6736(80)91403-8. [DOI] [PubMed] [Google Scholar]
  27. Hammond B., Fairman R. P., Monroe P., Glauser F. L., Sugarman H., Davis D. The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors. Am J Med Sci. 1985 Sep;290(3):98–101. doi: 10.1097/00000441-198509000-00003. [DOI] [PubMed] [Google Scholar]
  28. Hinds C. J. Monoclonal antibodies in sepsis and septic shock. BMJ. 1992 Jan 18;304(6820):132–133. doi: 10.1136/bmj.304.6820.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Holcroft J. W., Vassar M. J., Weber C. J. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial. Ann Surg. 1986 Apr;203(4):371–378. doi: 10.1097/00000658-198604000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hyers T. M., Tricomi S. M., Dettenmeier P. A., Fowler A. A. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991 Aug;144(2):268–271. doi: 10.1164/ajrccm/144.2.268. [DOI] [PubMed] [Google Scholar]
  31. Jacobs R. F., Tabor D. R., Burks A. W., Campbell G. D. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis. 1989 Dec;140(6):1686–1692. doi: 10.1164/ajrccm/140.6.1686. [DOI] [PubMed] [Google Scholar]
  32. Jansen J. H., Fibbe W. E., Willemze R., Kluin-Nelemans J. C. Interleukin-4. A regulatory protein. Blut. 1990 May;60(5):269–274. doi: 10.1007/BF01736226. [DOI] [PubMed] [Google Scholar]
  33. Kreuzfelder E., Joka T., Keinecke H. O., Obertacke U., Schmit-Neuerburg K. P., Nakhosteen J. A., Paar D., Scheiermann N. Adult respiratory distress syndrome as a specific manifestation of a general permeability defect in trauma patients. Am Rev Respir Dis. 1988 Jan;137(1):95–99. doi: 10.1164/ajrccm/137.1.95. [DOI] [PubMed] [Google Scholar]
  34. Leatherman J. W., Schmitz P. G. Fever, hyperdynamic shock, and multiple-system organ failure. A pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest. 1991 Nov;100(5):1391–1396. doi: 10.1378/chest.100.5.1391. [DOI] [PubMed] [Google Scholar]
  35. Lee C. T., Fein A. M., Lippmann M., Holtzman H., Kimbel P., Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med. 1981 Jan 22;304(4):192–196. doi: 10.1056/NEJM198101223040402. [DOI] [PubMed] [Google Scholar]
  36. Leeman M., Boeynaems J. M., Degaute J. P., Vincent J. L., Kahn R. J. Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome. Chest. 1985 Jun;87(6):726–730. doi: 10.1378/chest.87.6.726. [DOI] [PubMed] [Google Scholar]
  37. Leeper-Woodford S. K., Carey P. D., Byrne K., Fisher B. J., Blocher C., Sugerman H. J., Fowler A. A., 3rd Ibuprofen attenuates plasma tumor necrosis factor activity during sepsis-induced acute lung injury. J Appl Physiol (1985) 1991 Sep;71(3):915–923. doi: 10.1152/jappl.1991.71.3.915. [DOI] [PubMed] [Google Scholar]
  38. Leeuwenberg J. F., Van Damme J., Meager T., Jeunhomme T. M., Buurman W. A. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol. 1988 Sep;18(9):1469–1472. doi: 10.1002/eji.1830180925. [DOI] [PubMed] [Google Scholar]
  39. Lisi D. M. Muscle spasms and creatine phosphokinase elevation following salbutamol administration. Eur Respir J. 1989 Jan;2(1):98–98. [PubMed] [Google Scholar]
  40. Liu S. F., Crawley D. E., Barnes P. J., Evans T. W. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis. 1991 Jan;143(1):32–37. doi: 10.1164/ajrccm/143.1.32. [DOI] [PubMed] [Google Scholar]
  41. Liu S. F., Dewar A., Crawley D. E., Barnes P. J., Evans T. W. Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction. J Appl Physiol (1985) 1992 Mar;72(3):1044–1049. doi: 10.1152/jappl.1992.72.3.1044. [DOI] [PubMed] [Google Scholar]
  42. Maderazo E. G., Breaux S. P., Woronick C. L. Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci. 1984 Oct;73(10):1403–1406. doi: 10.1002/jps.2600731020. [DOI] [PubMed] [Google Scholar]
  43. Meduri G. U., Belenchia J. M., Estes R. J., Wunderink R. G., el Torky M., Leeper K. V., Jr Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991 Oct;100(4):943–952. doi: 10.1378/chest.100.4.943. [DOI] [PubMed] [Google Scholar]
  44. Meduri G. U., Belenchia J. M., Estes R. J., Wunderink R. G., el Torky M., Leeper K. V., Jr Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991 Oct;100(4):943–952. doi: 10.1378/chest.100.4.943. [DOI] [PubMed] [Google Scholar]
  45. Merritt T. A., Hallman M., Bloom B. T., Berry C., Benirschke K., Sahn D., Key T., Edwards D., Jarvenpaa A. L., Pohjavuori M. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med. 1986 Sep 25;315(13):785–790. doi: 10.1056/NEJM198609253151301. [DOI] [PubMed] [Google Scholar]
  46. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  47. Murray J. F., Matthay M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  48. Palder S. B., Huval W., Lelcuk S., Alexander F., Shepro D., Mannick J. A., Hechtman H. B. Reduction of polymorphonuclear leukocyte accumulations by inhibition of cyclooxygenase and thromboxane syntase in the rabbit. Surgery. 1986 Jan;99(1):72–81. [PubMed] [Google Scholar]
  49. Pepke-Zaba J., Higenbottam T. W., Dinh-Xuan A. T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9;338(8776):1173–1174. doi: 10.1016/0140-6736(91)92033-x. [DOI] [PubMed] [Google Scholar]
  50. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991 Dec 21;338(8782-8783):1557–1558. doi: 10.1016/0140-6736(91)92376-d. [DOI] [PubMed] [Google Scholar]
  51. Polla B. S. A role for heat shock proteins in inflammation? Immunol Today. 1988 May;9(5):134–137. doi: 10.1016/0167-5699(88)91199-1. [DOI] [PubMed] [Google Scholar]
  52. Rees D. D., Cellek S., Palmer R. M., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990 Dec 14;173(2):541–547. doi: 10.1016/s0006-291x(05)80068-3. [DOI] [PubMed] [Google Scholar]
  53. Repine J. E., Beehler C. J. Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. Am Rev Respir Dis. 1991 Aug;144(2):251–252. doi: 10.1164/ajrccm/144.2.251. [DOI] [PubMed] [Google Scholar]
  54. Richard C., Lemonnier F., Thibault M., Couturier M., Auzepy P. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med. 1990 Jan;18(1):4–9. doi: 10.1097/00003246-199001000-00002. [DOI] [PubMed] [Google Scholar]
  55. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976 Sep;184(3):333–341. doi: 10.1097/00000658-197609000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Slotman G. J., Burchard K. W., D'Arezzo A., Gann D. S. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma. 1988 May;28(5):648–654. doi: 10.1097/00005373-198805000-00015. [DOI] [PubMed] [Google Scholar]
  57. Stokke T., Burchardi H., Hensel I., Köstering H., Käthner T., Rahlf G. Continuous intravenous infusion of elastase in normal and agranulocytic minipigs--effects on the lungs and the blood coagulation system. Resuscitation. 1986 Sep;14(1-2):61–79. doi: 10.1016/0300-9572(86)90007-9. [DOI] [PubMed] [Google Scholar]
  58. Storck M., Hartl W. H., Zimmerer E., Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet. 1991 Feb 23;337(8739):452–455. doi: 10.1016/0140-6736(91)93393-n. [DOI] [PubMed] [Google Scholar]
  59. Strieter R. M., Remick D. G., Ward P. A., Spengler R. N., Lynch J. P., 3rd, Larrick J., Kunkel S. L. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1230–1236. doi: 10.1016/s0006-291x(88)81271-3. [DOI] [PubMed] [Google Scholar]
  60. Sullivan G. W., Carper H. T., Novick W. J., Jr, Mandell G. L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988 Jul;56(7):1722–1729. doi: 10.1128/iai.56.7.1722-1729.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Thijs L. G., Schneider A. J., Groeneveld A. B. The haemodynamics of septic shock. Intensive Care Med. 1990;16 (Suppl 3):S182–S186. doi: 10.1007/BF01709697. [DOI] [PubMed] [Google Scholar]
  62. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  63. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989 Oct 28;2(8670):997–1000. doi: 10.1016/s0140-6736(89)91013-1. [DOI] [PubMed] [Google Scholar]
  64. Voelkel N. F., Stenmark K. R., Reeves J. T., Mathias M. M., Murphy R. C. Actions of lipoxygenase metabolites in isolated rat lungs. J Appl Physiol Respir Environ Exerc Physiol. 1984 Sep;57(3):860–867. doi: 10.1152/jappl.1984.57.3.860. [DOI] [PubMed] [Google Scholar]
  65. Webster N. R., Cohen A. T., Nunn J. F. Adult respiratory distress syndrome--how many cases in the UK? Anaesthesia. 1988 Nov;43(11):923–926. doi: 10.1111/j.1365-2044.1988.tb05652.x. [DOI] [PubMed] [Google Scholar]
  66. Welsh C. H., Lien D., Worthen G. S., Weil J. V. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am Rev Respir Dis. 1988 Nov;138(5):1106–1114. doi: 10.1164/ajrccm/138.5.1106. [DOI] [PubMed] [Google Scholar]
  67. Wolf H. R., Seeger H. W. Experimental and clinical results in shock lung treatment with vitamin E. Ann N Y Acad Sci. 1982;393:392–410. doi: 10.1111/j.1749-6632.1982.tb31278.x. [DOI] [PubMed] [Google Scholar]
  68. Wright S. D., Detmers P. A. Adhesion-promoting receptors on phagocytes. J Cell Sci Suppl. 1988;9:99–120. doi: 10.1242/jcs.1988.supplement_9.5. [DOI] [PubMed] [Google Scholar]
  69. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]
  70. van Asbeck B. S., Hoidal J., Vercellotti G. M., Schwartz B. A., Moldow C. F., Jacob H. S. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science. 1985 Feb 15;227(4688):756–759. doi: 10.1126/science.2982213. [DOI] [PubMed] [Google Scholar]
  71. van der Meer J. W. The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection. Biotherapy. 1988;1(1):19–25. doi: 10.1007/BF02170132. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES